Skip to content

GENAPHAR

Active Public limited companyfounded 1976active for 50 yearsArteveldestraat 20, 1000 BrusselsKBO/BCE: BE 0416.169.095

Lifetime

20 annual accounts with figures on one time axis, 49 filings since 1977
peak of €49,204 in 2022
€18,365▲ 7.8%
lowest -€26,773 in 2023
€18,373▲ 78.3%
peak of €97,645 in 2025
€97,645▲ 23.2%
€49,685▼ 2.3%
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
24-09-202655 days late
2025micro format
Result from €10,305 to €18,373Equity from €79,272 to €97,645

Key points

from the 2025 annual accounts

Turnover

≈ €200,000 estimated

The accounts state no turnover.

Filings

49 annual accounts since 1977
AprilJune31 JulyOctober1980199520102025

Ten of the last ten came late. The 2025 accounts came in latest, 55 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,386 companies had the same profile as GENAPHAR has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,760 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,386 companies, not a prediction for GENAPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0416169095
First establishment PHARMACIE DE LA BOURSE, Arteveldestraat 20, Brussels
All 60 events

Comparable companies

same main activity, similar in size and age
Company
GENAPHAR Brussels €147,330 €18,365 66.3% -
APOTHEEK D'HONDT PASCAL Lokeren €177,633 €17,317 90.1% 0
X - PHARMA Verviers €150,150 €15,417 98.8% -
Apotheek J. DRAULANS Heusden-Zolder €215,560 €14,934 86.7% -
Pharmacie Van Dhelsen Seraing €226,711 €19,064 89.4% -
Apotheek Els De Smedt Beveren-Kruibeke-Zwijndrecht €157,911 €12,944 2.9% -
BOPRE Aalst €196,068 €28,972 50.9% -

These companies have the same main activity as GENAPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €150,000 and €227,000, founded between 1973 and 1994.

Official details

Source: KBO
Status
Active since 04-06-1976Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.012.426.0391000 Brussels, since 01-07-1976
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

€147,330▲ 13.2%
Filing
Filed on 24-09-2026
Financials

Insights on GENAPHAR

GENAPHAR files the micro format. That format states no turnover. The gross margin rose from €2,601 in 2006 to €18,365 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GENAPHAR

What is the company number of GENAPHAR?
The company number of GENAPHAR is 0416.169.095. The VAT number is the same number with BE in front: BE 0416.169.095.
Where is GENAPHAR based?
The registered office is at Arteveldestraat 20, 1000 Brussels.Company details
What does GENAPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of GENAPHAR?
GENAPHAR is a public limited company (NV).
When was GENAPHAR founded?
GENAPHAR was founded on 04-06-1976.
Is GENAPHAR still active?
Yes, GENAPHAR is an active enterprise in the KBO register.
What is the turnover of GENAPHAR?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €18,365 and 138 comparable companies (NACE 477). It probably lies between €72,000 and €420,000. It is a rough estimate.Financials
Is GENAPHAR profitable?
In financial year 2025, GENAPHAR made a profit of €18,373.
Where can I find the annual accounts of GENAPHAR?
GENAPHAR filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GENAPHAR due?
GENAPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.